MedPath

Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Phase 1
Recruiting
Conditions
Pancreatic Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Adenocarcinoma
Interventions
First Posted Date
2020-04-24
Last Posted Date
2023-08-28
Lead Sponsor
University of Chicago
Target Recruit Count
54
Registration Number
NCT04361708
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Leflunomide in Mild COVID-19 Patients

Phase 1
Terminated
Conditions
COVID-19
Interventions
First Posted Date
2020-04-24
Last Posted Date
2024-02-07
Lead Sponsor
University of Chicago
Target Recruit Count
11
Registration Number
NCT04361214
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Long Term Outcomes of Patients With COVID-19

Active, not recruiting
Conditions
Corona Virus Infection
Covid-19
Critical Illness
Respiratory Failure
Interventions
Other: Quality of Life
Other: Impact Event Score
Other: Hospital anxiety and depression scale
First Posted Date
2020-04-24
Last Posted Date
2024-12-09
Lead Sponsor
University of Chicago
Target Recruit Count
500
Registration Number
NCT04360538
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19

Phase 1
Completed
Conditions
COVID-19
Interventions
First Posted Date
2020-04-17
Last Posted Date
2023-02-23
Lead Sponsor
University of Chicago
Target Recruit Count
12
Registration Number
NCT04351620
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Low-dose Imaging Technique (LITE)

Not Applicable
Withdrawn
Conditions
Breast Cancer
Interventions
Diagnostic Test: Low-dose Imaging
First Posted Date
2020-04-17
Last Posted Date
2023-04-26
Lead Sponsor
University of Chicago
Registration Number
NCT04350957

Early Extubation for Patients With Acute Hypoxemic Respiratory Failure

Not Applicable
Withdrawn
Conditions
Mechanical Ventilation
Corona Virus Infection
Interventions
Device: Helmet non-invasive ventilation (NIV)
First Posted Date
2020-04-16
Last Posted Date
2024-05-02
Lead Sponsor
University of Chicago
Registration Number
NCT04349332
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)

Early Phase 1
Completed
Conditions
Breast Fibroadenoma
Breast Neoplasms
Breast Diseases
Breast Cancer
First Posted Date
2020-04-10
Last Posted Date
2023-12-05
Lead Sponsor
University of Chicago
Target Recruit Count
50
Registration Number
NCT04341129
Locations
🇺🇸

University of Chicago Medicine, Chicago, Illinois, United States

COVID-19 Convalescent Plasma

Early Phase 1
Completed
Conditions
Coronavirus
Interventions
Biological: anti-SARS-CoV-2 convalescent plasma
First Posted Date
2020-04-09
Last Posted Date
2024-02-28
Lead Sponsor
University of Chicago
Target Recruit Count
10
Registration Number
NCT04340050
Locations
🇺🇸

University of Chicago Medicine, Chicago, Illinois, United States

Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis

Phase 2
Completed
Conditions
COVID-19
Interventions
First Posted Date
2020-04-02
Last Posted Date
2022-06-09
Lead Sponsor
University of Chicago
Target Recruit Count
32
Registration Number
NCT04331795
Locations
🇺🇸

University of Chicago Medicine, Chicago, Illinois, United States

Implications of Anesthetics on Sleep Consolidation

Phase 4
Terminated
Conditions
Sleep
Interventions
First Posted Date
2020-04-01
Last Posted Date
2023-02-24
Lead Sponsor
University of Chicago
Target Recruit Count
9
Registration Number
NCT04329091
Locations
🇺🇸

University of Chicago Medicine, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy